Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (341-350 of 862) with videos related to

Pageof 87
Sort By:
Brain Research Bulletin|October 24, 2021
(R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in miceXingming Wang, Lijia Chang, Yunfei Tan, et al.
Brain Research Bulletin|February 14, 2022
Brain-spleen axis in health and diseases: A review and future perspectiveYan Wei, Tong Wang, Lei Liao, et al.
Pharmacology, Biochemistry, and Behavior|June 24, 2014
Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: a role for serotonin 5-HT1A receptorsNoriko Yoshimi, Yuko Fujita, Yuta Ohgi, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|December 3, 2002
Single-cell imaging of the Ca2+ influx into bovine endothelial cells occurring in response to an alternating electric stimulusHideaki Matsuoka, Kenji Hashimoto, Shigetoshi Horikiri, et al.
Science China. Life Sciences|November 17, 2025
Psychedelic therapy: a paradigm shift in treating neuropsychiatric disordersMeng Jin, Xiuna Ji, Xiaoxing Liu, et al.
Journal of Clinical Psychopharmacology|January 5, 2013
Ifenprodil for emotional incontinence in patients with vascular dementia: two case reportsAkira Kishimoto, Katsusuke Yatomi, Yoshitaka Yokoyama, et al.
Plos One|September 11, 2013
Low openness on the revised NEO personality inventory as a risk factor for treatment-resistant depressionMichio Takahashi, Yukihiko Shirayama, Katsumasa Muneoka, et al.
Psychopharmacology|July 27, 2021
(R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammationJiancheng Zhang, Li Ma, Xiayun Wan, et al.
Neuroscience Bulletin|November 24, 2016
Risks Associated with Misuse of Ketamine as a Rapid-Acting AntidepressantWeili Zhu, Zengbo Ding, Yinan Zhang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 18, 2015
Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptorsTamaki Ishima, Takashi Futamura, Yuta Ohgi, et al.
Pageof 87

Showing results (341-350 of 862) with videos related to

Sort By:
Pageof 87
Brain Research Bulletin|October 24, 2021
(R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in miceXingming Wang, Lijia Chang, Yunfei Tan, et al.
Brain Research Bulletin|February 14, 2022
Brain-spleen axis in health and diseases: A review and future perspectiveYan Wei, Tong Wang, Lei Liao, et al.
Pharmacology, Biochemistry, and Behavior|June 24, 2014
Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: a role for serotonin 5-HT1A receptorsNoriko Yoshimi, Yuko Fujita, Yuta Ohgi, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|December 3, 2002
Single-cell imaging of the Ca2+ influx into bovine endothelial cells occurring in response to an alternating electric stimulusHideaki Matsuoka, Kenji Hashimoto, Shigetoshi Horikiri, et al.
Science China. Life Sciences|November 17, 2025
Psychedelic therapy: a paradigm shift in treating neuropsychiatric disordersMeng Jin, Xiuna Ji, Xiaoxing Liu, et al.
Journal of Clinical Psychopharmacology|January 5, 2013
Ifenprodil for emotional incontinence in patients with vascular dementia: two case reportsAkira Kishimoto, Katsusuke Yatomi, Yoshitaka Yokoyama, et al.
Plos One|September 11, 2013
Low openness on the revised NEO personality inventory as a risk factor for treatment-resistant depressionMichio Takahashi, Yukihiko Shirayama, Katsumasa Muneoka, et al.
Psychopharmacology|July 27, 2021
(R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammationJiancheng Zhang, Li Ma, Xiayun Wan, et al.
Neuroscience Bulletin|November 24, 2016
Risks Associated with Misuse of Ketamine as a Rapid-Acting AntidepressantWeili Zhu, Zengbo Ding, Yinan Zhang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 18, 2015
Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptorsTamaki Ishima, Takashi Futamura, Yuta Ohgi, et al.
Pageof 87